[ACL] QoQ Quarter Result on 30-Jun-2022 [#Q4]

Stock
[ACL] Australian Clinical Labs Limited
Announcement Date
28-Jun-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q4]
Profit Trend
QoQ- 100.00%
YoY- 1,355.45%
Quarter Report
ACL's Result
ACL's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Revenue 168,380 360,312 180,156 457,603 228,802 538,001 269,001 -26.84%
PBT 7,777 32,756 16,378 69,956 34,978 184,944 92,472 -80.83%
Tax 2,497 7,274 3,637 21,842 10,921 54,656 27,328 -79.74%
NP 5,240 25,421 12,711 48,030 24,015 130,214 65,107 -81.38%
Tax Rate -32.11% -22.21% -22.21% -31.22% -31.22% -29.55% -29.55% -
Total Cost 163,140 334,891 167,446 409,573 204,787 407,787 203,894 -13.82%
Ratio Analysis
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
NP Margin 3.11 7.06 7.06 10.50 10.50 24.20 24.20 -74.56%
Per Share
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
EPS 0.03 0.13 0.06 0.24 0.12 0.65 0.32 -79.39%
EPS Diluted 0.03 0.13 0.06 0.24 0.12 0.65 0.32 -79.39%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.